📢 Notice: Admission is ongoing for ARDMS 10th Batch 💠 ADMS & DMU new batch will start from 17th January  💠 CMU new batch will start from 17th January  💠

We Are The Leading Experts In Ultrasound Training & ARDMS Exam Preparation.

CA 19.9Elisa Kit

Category:

Description

Product Information: CA 19.9 ELISA Kit

Overview

The CA 19.9 ELISA Kit is a high-quality diagnostic tool designed for the quantitative detection of carbohydrate antigen 19.9 (CA 19.9) levels in human serum or plasma. CA 19.9 is a tumor-associated carbohydrate antigen widely used as a biomarker for pancreatic cancer and other gastrointestinal malignancies. This ELISA kit provides precise, reliable, and reproducible results, making it suitable for clinical diagnostics and research applications.


Key Features

  • High Sensitivity and Specificity: Optimized for accurate quantification of CA 19.9 with minimal cross-reactivity.
  • User-Friendly Protocol: Easy-to-follow instructions with minimal hands-on time, suitable for both experienced and new users.
  • Reliable Results: Ensures consistent performance with low variability between assays.
  • Wide Applicability: Suitable for use in diagnostic laboratories, clinical research, and academic studies.
  • Ready-to-Use Components: Includes all necessary reagents, controls, and standards for a complete assay.

Kit Components

  1. Microtiter Plate (pre-coated with anti-CA 19.9 antibodies)
  2. Standards (pre-calibrated for accurate quantification)
  3. Controls (positive and negative)
  4. Sample Diluent and Assay Buffer
  5. Enzyme-Conjugate Reagent
  6. Substrate Solution (TMB)
  7. Stop Solution
  8. Wash Buffer (concentrated)
  9. Detailed Instruction Manual

Specifications

  • Assay Type: Sandwich ELISA
  • Sample Type: Human serum or plasma
  • Assay Time: ~2.5 hours
  • Detection Range: 0 U/mL – X U/mL (dependent on kit specifications)
  • Sensitivity: As per manufacturer standards
  • Storage Conditions: Store at 2-8°C

Applications

  • Cancer Diagnostics: Screening and monitoring pancreatic, gastric, and colorectal cancers.
  • Therapeutic Monitoring: Assessing treatment efficacy in cancer patients.
  • Research: Studying CA 19.9 expression and its correlation with disease progression.

Ordering Information

  • Catalog Number: [Insert Catalog Number]
  • Package Size: [Insert Package Details, e.g., 96 wells]
  • Shelf Life: [Insert Duration, e.g., 12 months from manufacturing]

Additional Notes

  • This kit is for in vitro diagnostic use only.
  • Follow the provided manual for optimal performance and accurate results.
  • Consult your local regulatory guidelines for clinical applications.

Reviews

There are no reviews yet.

Be the first to review “CA 19.9Elisa Kit”

Your email address will not be published. Required fields are marked *